Mammary adenocarcinoma was induced by administering 7, 12-dimethylbenz (a) anthracene to inbred female Fischer-344 rats. Then cell suspensions of this mammary cancer were subcutaneously inoculated into other rats of the same strain to obtain transplantable mammary cancer. The transplantable mammary cancer cells were subsequently injected into the femoral medullary cavity of other rats of the same strain to prepare a metastatic bone tumor model.
Malignant
bone tumors arising in humans are generally difficult to cure, have a poor prognosis, and very often cause intolerable pain and disability.
Primary malignant bone tumors, although rare, tend to be more frequent in younger individuals and have a profound effect on the future of such patients. On the other hand, metastatic bone tumors are usually found in comparatively elderly patients, in whom they arise from malignancies such as carcinoma of the lung, breast, and prostate.
The prognosis is often unfavorable for such patients, because metastasis occurs after surgical treatment, radiotherapy, and/or chemotherapy for the primary tumor. Therefore, success with cancer therapy depends on both the curability of the primary lesion and the prevention of metastasis.
The mechanism of cancer metastasis has not yet been fully elucidated either experimentally or clinically. In this study, we prepared experimental bone metastase in rats, and subjected the resulting lesions to histologic and radiologic examination.
Materials and methods

Animals
This study used inbred female Fischer-344 rats purchased from Japan Clea Co. (Tokyo). Two animals were housed together in stainless steel cages which throughout the experiment. The animals were provided with a pellet diet (CE-2, Japan Clea Co., Tokyo) and tap water ad libitum.
Induction of mammary cancer Mammary cancer was induced with an olive oil solution of 7, 12-dimethylbenz (a) anthracene (DMBA) (Eastman Kodak Co., Rochester, USA), which was given orally to the rats twice at the ages of 8 and 9 weeks (30mg/kg each time). The rats given DMBA were examined once a week to detect the development diameter were dissected out for transplantation.
Transplantation
The DMB A-induced mammary cancers were histologically shown to be adenocarcinomas.
The dissected tumor tissue was cut into thin slices with scissors under sterile conditions, and was made into a cell suspension by simple mechanical compression using rubber. After phosphate-buffered saline (pH7.4) containing 1% trypsin (Difco co., 250:1) was added to the tumor suspension for digestion, cancer cells were isolated by centrifugation at 600G. Then the (1ml) were injected subcutaneously into rats of the same strain at the mammary line of the ventral chest wall.
Mammary cancer cells which acquired transplantability by this procedure were subsequently maintained by injecting them into the subcutaneous tissue of the lateral chest wall of rats of the same strain every 6 weeks.
Transplantation of mammary cancer cells into medullary cavity
Intraosseous transplantation of mammary cancer cells cell suspension) into the left femoral medullary cavity of rats by direct injection with 21 G needle through the anterior intercondylar fossa under Nembutal anesthesia (Fig. 1A ).
Histological examination Bone tissue for histological examination was operatively resected with scissors, fixed in 10% phosphate-buffered formalin solution for 1 week, and then decalcified in 3% ethylenediaminetetraacetic acid sodium salt solution (EDTA). The tissue was then embedded in paraffin and stained with hematoxylin and eosin. Radiography and X-ray irradiation Radiographs were taken using a portable X-ray machine (KCD-10M-6AT, Toshiba Co., Tokyo), and X-ray irradiation was performed using a 4 MeV linear accelerator (Linac, NEC, Tokyo).
Statistical analysis
Calculation of cumulative survival rates was done by the Kaplan-Meier method1), while statistical analysis of the significance of differences was done with the generalized Wilcoxon test2).
Results
Induction and transplantation of mammary cancer DMBA was given orally to 48 female Fischer rats from the age of 8 weeks, and 45 of them survived for at least 25 weeks. Macroscopic cancer growth was observed in 37 rats by 25 weeks after administration. These tumors were categorized as follows: 8 papillary adenocarcinomas, 13 medullary carcinomas, 2 scirrhous carcinomas, 14 fibroadenomas, 5 mixed malignancies comprising papillary adenocarcinoma and medullary carcinoma, and 14 mixed tumors comprising adenocarcinoma and fibroadenoma. There were no tumors in 8 rats. All the papillary adenocarcinomas and medullary carcinomas were subjected to transplantation, and these cancers were all successfully transplanted. In the present study, one of these transplantable mammary tumors was used.
When the transplantable mammary cancer cells obtained as mentioned above were injected into the femoral medullary cavity, they continued to proliferate in all cases, causing osteolysis and periosteal new bone Light microphotograph of a lung metastasis of the transplantable mammary cancer formation ( Fig.1) that was followed by fracture. Finally, after progressive bone destruction (Fig. 5) , the rats died while bearing large cancers which had grown very rapidly.
Characteristics of tumor proliferation in bone Fig. 2 show the cumulative survival rate data for rats tissue of the lateral chest wall or into the femur, and for rats which underwent X-ray irradiation (45Gy) of the tumor-injected bone at 1 week after inoculation. Fig. 3 shows a Lineac radiograph taken for verification Anteroposterior radiographs of the femurs of rats with transplantable mammary cancer during X-ray irradiation of the femur.
As shown in Fig. 2 , the mean survival time was of cancer cells, and was significantly shorter than after
In the rats which received intraosseous transplantation, X-ray irradiation prolonged the mean survival time to
When transplantable mammary cancer cells were injected into the femoral medullary cavity, pulmonary metastase almost always developed at an early stage following inoculation. Figure 4 shows the histological appearance of pulmonary metastases 5 days after the intraosseous transplantation of cancer cells. No pulmonary metastase developed in any of the rats given subcutaneous inoculations of mammary cancer cells. 
Histological bone changes after cancer cell transplantation
When cancer cells were injected into the medullary cavity, the surrounding tissues underwent sudden changes. Fig. 6 shows a photomicrograph of the endosteum and periosteum in the metaphyseal region obtained 11 days after inoculation of transplantable mammary cancer cells into the femoral marrow cavity. Bone resorption by osteoclasts can be seen to affect both the endosteum and the periosteum. have studied lymph node metastasis using transplantable mammary cancer cells and the inbred rats10).
More recently, Yamasaki et al.11 ) prepared an animal model of bone metastasis using transplantable osteogenic tumors obtained by the administration of radioactive phosphorus to rats. Transplantable osteogenic tumor cells were injected subperiosteally into the tibia.
We prepared transplantable mammary carcinoma cells by the serial transplantation of mammary cancers produced by administration of a chemical carcinogen to inbred rats. These transplantable mammary cancer cells were injected with 21 G needle into the femoral marrow of rats to prepare a model of bone metastasis. After transplantation of the mammary cancer cells, bone resorption by osteoclasts affected both the endosteum and the periosteum, new bone formation by osteoblasts occurred on the surface of the periosteum, and a series of phenomena involving bone remodeling and fracture were observed due to accelerated bone resorption by activated osteoclasts in association with rapid tumor proliferation.
The general course of tumor metastasis is that tumor 
